KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Arbutus Biopharma (ABUS) Dividends Paid - Preferred (2018 - 2021)

Arbutus Biopharma's Dividends Paid - Preferred history spans 4 years, with the latest figure at $574000.0 for Q4 2021.

  • For Q4 2021, Dividends Paid - Preferred fell 81.62% year-over-year to $574000.0; the TTM value through Sep 2022 reached $574000.0, down 96.09%, while the annual FY2021 figure was $12.1 million, 0.13% changed from the prior year.
  • Dividends Paid - Preferred for Q4 2021 was $574000.0 at Arbutus Biopharma, down from $5.1 million in the prior quarter.
  • Across five years, Dividends Paid - Preferred topped out at $5.7 million in Q4 2019 and bottomed at $574000.0 in Q4 2021.
  • The 4-year median for Dividends Paid - Preferred is $3.0 million (2020), against an average of $3.1 million.
  • The largest YoY upside for Dividends Paid - Preferred was 68.05% in 2021 against a maximum downside of 81.62% in 2021.
  • A 4-year view of Dividends Paid - Preferred shows it stood at $2.6 million in 2018, then soared by 120.96% to $5.7 million in 2019, then plummeted by 44.94% to $3.1 million in 2020, then plummeted by 81.62% to $574000.0 in 2021.
  • Per Business Quant, the three most recent readings for ABUS's Dividends Paid - Preferred are $574000.0 (Q4 2021), $5.1 million (Q3 2021), and $3.3 million (Q2 2021).